bibliographic resource 6575 [br/6575]
https://w3id.org/oc/corpus/br/6575

is a
title
  • PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer
publication date
  • 2014-01-01
contributor
format
identifier
part of